305841-29-6

Basic information

• Product Name: Sagopilone
• Synonyms: SAGOPILONE;(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-5-benzothiazolyl)-10-(2-propen-1-yl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione;De 03757;Unii-ky72ju32fo;Zk-epo;ZK 219477;BFZKMNSQCNVFGM-HQMJALQOSA-N
• CAS NO: 305841-29-6
• Molecular Formula: C30H41NO6S
• Molecular Weight: 543.71
• Mol File: 305841-29-6.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 711.9±60.0 °C(Predicted)
• Appearance: /
• Density: 1.153
• PKA: 13.53±0.70(Predicted)
• CAS DataBase Reference: Sagopilone(CAS DataBase Reference)
• NIST Chemistry Reference: Sagopilone(305841-29-6)
• EPA Substance Registry System: Sagopilone(305841-29-6)

Safety Data

• Hazardous Substances Data: 305841-29-6(Hazardous Substances Data)

Usage

General Description

Sagopilone is a synthetic and experimental chemotherapeutic agent belonging to the class of drugs known as epothilones, which are derived from a type of bacterium. It works by disrupting the structure and function of microtubules in cancer cells, ultimately leading to cell death. Sagopilone has shown promising results in preclinical and clinical studies for the treatment of various types of cancer, including breast cancer, non-small cell lung cancer, and ovarian cancer. However, due to its complex synthesis and potential side effects, further research is needed to fully understand its therapeutic benefits and safety profile.